Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)
Close on Nov 18, 2026Market cap $374.43MP/E –Yield –
Eupraxia Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
No operating income figures for Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?